N-isobutyl-4-methoxy-N-phenylbenzenesulfonamide | 882848-17-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-isobutyl-4-methoxy-N-phenylbenzenesulfonamide
• 英文别名: 4-methoxy-N-(2-methylpropyl)-N-phenylbenzenesulfonamide
• CAS: 882848-17-1
• 化学式: C₁₇H₂₁NO₃S
• 分子量: 319.425
• InChiKey: GOBDBIGWYKKWSA-UHFFFAOYSA-N

物化性质

• 沸点：
  444.8±47.0 °C(Predicted)
• 密度：
  1.178±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.55
• 重原子数：
  22.0
• 可旋转键数：
  6.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  46.61
• 氢给体数：
  0.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  N-isobutyl-4-methoxy-N-phenylbenzenesulfonamide 在 2,4,6-三甲基吡啶 、 lithium iodide 、 盐酸 、 水 作用下， 以 甲基叔丁基醚 为溶剂， 反应 11.0h， 生成 4-hydroxy-N-isobutyl-N-phenylbenzenesulfonamide
  参考文献：
  名称：

  [EN] N-TYPE CALCIUM CHANNEL INHIBITOR
  [FR] INHIBITEUR DE CANAL DE CALCIUM DE TYPE N

  摘要：

  This invention relates to an N-type calcium channel inhibitor drug containing a compound having an N-type calcium channel inhibitory action represented by the general formula (I) (wherein the symbols are as described in the specification), its salt, solvate, or prodrug. Since the compound of the present invention has an N-type calcium channel inhibitory action, it is useful as a preventive and/or therapeutic agent for N-type calcium channel-mediated diseases such as pain (e.g., acute pain, chronic pain, postoperative pain, cancer pain, neuropathic pain, infectious pain, etc.), cerebral infarction, transient cerebral ischemic attack, brain and spinal cord disorders after cardiac surgery, spinal cord vascular disorders, stress-induced hypertension, neurosis, epilepsy, asthma, frequent urination, eye diseases, etc.

  公开号：

  WO2006038594A1
• 作为产物：
  描述：

  碘代异丁烷 、 4-甲氧基-N-苯基苯磺酰胺 在 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 N-isobutyl-4-methoxy-N-phenylbenzenesulfonamide
  参考文献：
  名称：

  [EN] N-TYPE CALCIUM CHANNEL INHIBITOR
  [FR] INHIBITEUR DE CANAL DE CALCIUM DE TYPE N

  摘要：

  This invention relates to an N-type calcium channel inhibitor drug containing a compound having an N-type calcium channel inhibitory action represented by the general formula (I) (wherein the symbols are as described in the specification), its salt, solvate, or prodrug. Since the compound of the present invention has an N-type calcium channel inhibitory action, it is useful as a preventive and/or therapeutic agent for N-type calcium channel-mediated diseases such as pain (e.g., acute pain, chronic pain, postoperative pain, cancer pain, neuropathic pain, infectious pain, etc.), cerebral infarction, transient cerebral ischemic attack, brain and spinal cord disorders after cardiac surgery, spinal cord vascular disorders, stress-induced hypertension, neurosis, epilepsy, asthma, frequent urination, eye diseases, etc.

  公开号：

  WO2006038594A1